ZymoGenetics price target cut by Merrill

ZymoGenetics Inc. was maintained by Merrill Lynch analyst Hari Sambasivam at a buy rating but the price target on the stock was cut to $25.50 per share from $26.50 following its secondary offering of 7.5 million shares. ZymoGenetics shares Monday dropped $0.99, or 5.88%, to close at $15.84 on volume of 1,143,299 shares versus the three-month running average of 207,234 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.